FDA to weigh easing limits on unproven peptides The FDA just changed the rules on peptides effective April 15, 2026. BPC 157, GHK Cu, MOTS C, and TB 500 have been removed from the Category 2 restricted compounding list. Here is what Is BPC 157 Banned? Oral vs. Injectable Forms Explained How did BPC 157 become the wellness industry's star peptide? FDA Compliance for Peptide Therapy and BPC 157 Holt Law